Aby Joiakim

Differential Susceptibilities of Murine Hepatoma 1c1c7 and Tao Cells to the Lysosomal Photosensitizer NPe6: Influence of Aryl Hydrocarbon Receptor on Lysosomal Fragility and Protease Contents

Joseph A. Caruso, Patricia Mathieu, Aby Joiakim et al. · Molecular Pharmacology · 2004 · 61 citations

Aryl Hydrocarbon Receptor Modulation of Tumor Necrosis Factor-α-induced Apoptosis and Lysosomal Disruption in a Hepatoma Model That Is Caspase-8-independent

Joseph A. Caruso, Patricia Mathieu, Aby Joiakim et al. · Journal of Biological Chemistry · 2006 · 51 citations · Full text

THE JUN N-TERMINAL KINASE INHIBITOR SP600125 IS A LIGAND AND ANTAGONIST OF THE ARYL HYDROCARBON RECEPTOR

Aby Joiakim, Patricia Mathieu, Christine Palermo et al. · Drug Metabolism and Disposition · 2003 · 49 citations

Superinduction of CYP1A1 in MCF10A Cultures by Cycloheximide, Anisomycin, and Puromycin: A Process Independent of Effects on Protein Translation and Unrelated to Suppression of Aryl Hydrocarbon Receptor Proteolysis by the Proteasome

Aby Joiakim, Patricia Mathieu, Althea A. Elliott et al. · Molecular Pharmacology · 2004 · 39 citations

Suppression of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-mediated aryl hydrocarbon receptor transformation and CYP1A1 induction by the phosphatidylinositol 3-kinase inhibitor 2-(4-morpholinyl)-8-phenyl-4H-1- benzopyran-4-one (LY294002)

Meng Guo, Aby Joiakim, John J. Reiners · Biochemical Pharmacology · 2000 · 33 citations

Biochemistry, Functional Selectivity, Medicine +8